Internal Medicine, Endocrinology, Diabetes, & Metabolism · Stoughton, MA
NPI
1578618906
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
150 York St
Stoughton, MA, 02072
Phone (781) 297-1385
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
889 services
Medicare patients, 2024
483
Average age 73
Drug cost, 2024
$3.2M
6,311 prescriptions
Company payments, 2025
$402
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Howard A Fogel was code 99213 (office e&m - established), 612 times for 410 patients. In total Howard A Fogel billed 889 services in 10 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 612 | 410 | $71.72 | $44K |
| 99213 Office E&M - Established | Facility | 118 | 118 | $24.06 | $2,839 |
| 99214 Office E&M - Established | Office | 66 | 51 | $103.08 | $6,803 |
| 99204 Office E&M - New | Office | 37 | 37 | $131.70 | $4,873 |
| 99204 Office E&M - New | Facility | 12 | 12 | $66.08 | $793 |
By year: 2022 $63K for 1,132 services; 2023 $65K for 1,156 services; 2024 $62K for 889 services.
Medicare prescription drug claims, 2024
In 2024, the drug Howard A Fogel prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 417 prescriptions and refills. In total Howard A Fogel wrote 6,311 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 417 | 796 | 98 | $447K |
| Metformin Hcl Generic | 411 | 1,020 | 117 | $3,352 |
| Levothyroxine Sodium Generic | 379 | 1,040 | 116 | $3,427 |
| Ozempic Semaglutide | 303 | 535 | 72 | $503K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 280 | 623 | 73 | $194K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 259 | 626 | 84 | $49K |
| Trulicity Dulaglutide | 184 | 294 | 45 | $295K |
| Farxiga Dapagliflozin Propanediol | 168 | 403 | 46 | $218K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 166 | 378 | 59 | $15K |
| Atorvastatin Calcium Generic | 161 | 416 | 47 | $2,700 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 159 | 362 | 54 | $18K |
| Metformin Hcl Er Metformin Hcl | 149 | 404 | 46 | $2,400 |
| Humalog Kwikpen U-100 Insulin Lispro | 139 | 275 | 40 | $53K |
| Pioglitazone Hcl Generic | 125 | 328 | 41 | $2,376 |
| Novolog Flexpen Insulin Aspart | 123 | 210 | 59 | $34K |
Brand drugs: 3,338 claims; generic drugs: 2,394 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Howard A Fogel $402 ($402 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $96.53.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $96.53 |
| Abbott Laboratories ABT | 4 | $81.68 |
| Esperion Therapeutics, Inc. ESPR | 2 | $38.65 |
| Lilly USA, LLC LLY | 2 | $36.87 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $22.82 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $21.5 |
| Sequel Med Tech, LLC | 1 | $20.31 |
| Xeris Pharmaceuticals, Inc. | 1 | $19.97 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $16.81 |
| Medtronic, Inc. MDT | 1 | $16.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.